These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31735550)

  • 41. Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrol.
    Huang Y; Zhou D; Hang T; Wu Z; Liu J; Xu Q; Xie X; Zuo J; Wang Z; Zhou Y
    Anticancer Drugs; 2012 Jun; 23(5):515-24. PubMed ID: 22343423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons.
    Kachnic LA; Li L; Fournier L; Ferraiolo N; Dahm-Daphi J; Borgmann K; Willers H
    Cancer Lett; 2011 Jun; 305(1):86-93. PubMed ID: 21414716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas.
    Wei X; Meel MH; Breur M; Bugiani M; Hulleman E; Phoenix TN
    Acta Neuropathol Commun; 2021 Aug; 9(1):142. PubMed ID: 34425907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma.
    He C; Xu K; Zhu X; Dunphy PS; Gudenas B; Lin W; Twarog N; Hover LD; Kwon CH; Kasper LH; Zhang J; Li X; Dalton J; Jonchere B; Mercer KS; Currier DG; Caufield W; Wang Y; Xie J; Broniscer A; Wetmore C; Upadhyaya SA; Qaddoumi I; Klimo P; Boop F; Gajjar A; Zhang J; Orr BA; Robinson GW; Monje M; Freeman Iii BB; Roussel MF; Northcott PA; Chen T; Rankovic Z; Wu G; Chiang J; Tinkle CL; Shelat AA; Baker SJ
    Nat Commun; 2021 Jul; 12(1):4089. PubMed ID: 34215733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability.
    Zhang Y; Chang JF; Sun J; Chen L; Yang XM; Tang HY; Jing YY; Kang X; He ZM; Wu JY; Wei HM; Wang DL; Xu RG; Zhu RB; Shen Y; Zeng SY; Wang C; Liu KN; Zhang Y; Mao ZY; Jiang CZ; Sun FL
    J Cell Sci; 2018 Jun; 131(12):. PubMed ID: 29760279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage.
    Ohashi A; Zdzienicka MZ; Chen J; Couch FJ
    J Biol Chem; 2005 Apr; 280(15):14877-83. PubMed ID: 15671039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance.
    Krumm A; Barckhausen C; Kücük P; Tomaszowski KH; Loquai C; Fahrer J; Krämer OH; Kaina B; Roos WP
    Cancer Res; 2016 May; 76(10):3067-77. PubMed ID: 26980768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models.
    Martinez-Velez N; Marigil M; García-Moure M; Gonzalez-Huarriz M; Aristu JJ; Ramos-García LI; Tejada S; Díez-Valle R; Patiño-García A; Becher OJ; Gomez-Manzano C; Fueyo J; Alonso MM
    Acta Neuropathol Commun; 2019 Apr; 7(1):64. PubMed ID: 31036068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells.
    Kramer D; Stark N; Schulz-Heddergott R; Erytch N; Edmunds S; Roßmann L; Bastians H; Concin N; Moll UM; Dobbelstein M
    Cell Death Differ; 2017 Feb; 24(2):300-316. PubMed ID: 27834954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FANCD2 Facilitates Replication through Common Fragile Sites.
    Madireddy A; Kosiyatrakul ST; Boisvert RA; Herrera-Moyano E; García-Rubio ML; Gerhardt J; Vuono EA; Owen N; Yan Z; Olson S; Aguilera A; Howlett NG; Schildkraut CL
    Mol Cell; 2016 Oct; 64(2):388-404. PubMed ID: 27768874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sex-specific hepatic lipid and bile acid metabolism alterations in
    Moore ES; Daugherity EK; Karambizi DI; Cummings BP; Behling-Kelly E; Schaefer DMW; Southard TL; McFadden JW; Weiss RS
    J Biol Chem; 2019 Oct; 294(43):15623-15637. PubMed ID: 31434739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Significance of
    Komatsu H; Masuda T; Iguchi T; Nambara S; Sato K; Hu Q; Hirata H; Ito S; Eguchi H; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
    Anticancer Res; 2017 Mar; 37(3):1083-1090. PubMed ID: 28314268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Forkhead transcription factor FoxF1 interacts with Fanconi anemia protein complexes to promote DNA damage response.
    Pradhan A; Ustiyan V; Zhang Y; Kalin TV; Kalinichenko VV
    Oncotarget; 2016 Jan; 7(2):1912-26. PubMed ID: 26625197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma.
    Bailey CP; Figueroa M; Gangadharan A; Yang Y; Romero MM; Kennis BA; Yadavilli S; Henry V; Collier T; Monje M; Lee DA; Wang L; Nazarian J; Gopalakrishnan V; Zaky W; Becher OJ; Chandra J
    Neuro Oncol; 2020 Sep; 22(9):1302-1314. PubMed ID: 32166329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
    Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
    Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models.
    Haase S; Banerjee K; Mujeeb AA; Hartlage CS; Núñez FM; Núñez FJ; Alghamri MS; Kadiyala P; Carney S; Barissi MN; Taher AW; Brumley EK; Thompson S; Dreyer JT; Alindogan CT; Garcia-Fabiani MB; Comba A; Venneti S; Ravikumar V; Koschmann C; Carcaboso ÁM; Vinci M; Rao A; Yu JS; Lowenstein PR; Castro MG
    J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36125896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted mass spectrometry enables robust quantification of FANCD2 mono-ubiquitination in response to DNA damage.
    Whiteaker JR; Zhao L; Ivey RG; Sanchez-Bonilla M; Moore HD; Schoenherr RM; Yan P; Lin C; Shimamura A; Paulovich AG
    DNA Repair (Amst); 2018 May; 65():47-53. PubMed ID: 29605812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Histone H3K9 methyltransferase SETDB1 overexpression correlates with pediatric high-grade gliomas progression and prognosis.
    Klonou A; Korkolopoulou P; Giannopoulou AI; Kanakoglou DS; Pampalou A; Gargalionis AN; Sarantis P; Mitsios A; Sgouros S; Papavassiliou AG; Piperi C
    J Mol Med (Berl); 2023 Apr; 101(4):387-401. PubMed ID: 36811655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
    Kalb R; Neveling K; Hoehn H; Schneider H; Linka Y; Batish SD; Hunt C; Berwick M; Callen E; Surralles J; Casado JA; Bueren J; Dasi A; Soulier J; Gluckman E; Zwaan CM; van Spaendonk R; Pals G; de Winter JP; Joenje H; Grompe M; Auerbach AD; Hanenberg H; Schindler D
    Am J Hum Genet; 2007 May; 80(5):895-910. PubMed ID: 17436244
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study.
    Zhou YX; Huang YL
    Chin Med J (Engl); 2009 Jul; 122(14):1666-73. PubMed ID: 19719969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.